IP Library Granted Patent US 7,615,350
Granted Patent B2
US 7,615,350 · App. 11/874,407 · Granted Nov 10, 2009

Methods for haplotyping genomic DNA

Assignees: Fred Hutchinson Cancer Research Center; Institute for Systems Biology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,615,350
App. No.
11/874,407
Granted
Nov 10, 2009
Kind
B2
Abstract

The present invention provides a novel method for specifically isolating and separating large segments of genomic DNA that can subsequently be used to determine a genomic haplotype. The invention relies on using a solid phase having a flat surface arrayed with oligonucleotides designed to specifically hybridize to each particular haplotype of an individual sample, e.g., oligonucleotides designed to specifically hybridize with each of the two HLA-B haplotypes, HLA-A, HLA-C, HLA-DR, HLA-DQ, and the like. The genomic DNA is contacted and hybridized to the arrayed oligonucleotides to form a genomic DNA/oligonucleotide complex. The excess genomic DNA is washed away and the haplotype separated genomic DNA is denatured from the oligonucleotide probe and collected. The method of the present invention allows for the separation of genomic DNA fragments of between approximately 2 to about 4 megabases (Mb). Separation of the haplotypes of large genomic DNA fragments allows for linkage analysis of other HLA alleles and polymorphisms, microsatellite, SNPs, and the like across a large span of the HLA region, including HLA-A, -B, -C, and HLA-DRB1 regions. This linkage analysis is particularly useful when HLA typing for an individual with limited family HLA typing available.

Claims (25)

1. A method for determining cis linkage of alleles to a genomic locus haplotype, comprising:

(a) providing a solid surface comprising a covalently bound plurality of oligonucleotide probes having a nucleotide sequence complementary to said genomic locus haplotype;

(b) contacting the oligonucleotide probe with a sample of genomic DNA under conditions conducive to specific hybridization of the genomic DNA to the oligonucleotide probe to form a genomic DNA/oligonucleotide complex;

(c) removing excess genomic DNA;

(d) denaturing the genomic DNA/oligonucleotide complex;

(e) separating the genomic DNA by haplotype;

(f) amplifying selectively a region of interest in the haplotype separated genomic DNA using asymmetric PCR and labeled primers to form a labeled, single stranded DNA sample;

(g) contacting the labeled, single stranded DNA sample with a microarray comprising a plurality of oligonucleotide probes under conditions conducive to hybridization; and

(i) detecting a hybridization pattern for the DNA sample and assigning the allele type with cis linkage to the locus haplotype of the genomic DNA sample.

2. A method for separating large fragments of genomic DNA by haplotype, wherein said large fragments of genomic DNA have a length of 2 megabases (Mb) to 4 megabases (Mb), comprising:

(a) providing a solid surface comprising covalently bound oligonucleotide probes having a nucleotide sequence complementary to each haplotype of an allele;

(b) contacting the oligonucleotide probe with a sample of said large fragments of genomic DNA under conditions conducive to specific hybridization of the genomic DNA to the oligonucleotide probes to form a genomic DNA/oligonucleotide complex;

(c) removing excess genomic DNA;

(d) denaturing the genomic DNA/oligonucleotide complex; and

(e) separately collecting the genomic DNA corresponding to each haplotype; thereby separating the large fragments of genomic DNA by haplotype.

3. The method according to claim 2 , wherein the oligonucleotide probes are about 20 to about 40 bases in length.

4. The method according to claim 2 , wherein the oligonucleotide probes are spaced to allow independent manipulation of the genomic DNA hybridized to each probe.

5. The method of claim 2 , wherein the hybridization is carried out at a temperature of less than 30 degrees Celsius for 3 hours or more.

6. The method according to claim 2 , wherein the solid surface comprises glass.

7. The method according to claim 2 , wherein the solid surface is flat.

8. The method according to claim 2 , wherein the solid surface has been derivatized with a vapor phase deposition of an aminoalkyltrialkoxysilane.

9. The method according to claim 8 , wherein the aminoaklyltrialkoxysilane is 3-aminopropyltrimethoxylsilane.

10. The method according to claim 2 , wherein said covalently bound oligonucleotide probes further comprise a linking group, and wherein said linking group is sufficient to provide optimum binding of said fragments of genomic DNA to said oligonucleotide probes.

11. The method according to claim 2 , wherein said removing step is carried out by washing with buffer.

12. The method according to claim 10 , wherein said linking group is a poly dT spacer.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 12, 2013
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031003/0692 →
CONFIRMATORY LICENSE Recorded Sep 20, 2010
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025008/0162 →
Continuity (3)
Continuation 1084398500 · May 12, 2004
Provisional Application 6047032200 · May 12, 2003
Related Publication 20080125324A1 · May 29, 2008